Existence of a Threshold for the Genotoxic Carcinogens: Evidence from Mechanism-based Carcinogenicity Studies

Genes and Environment

Volumn 31, Issue 2, 2009, Pages 33-36

  Fukushima, Shoji ^a   Kakehashi, Anna ^b   Wei, Min ^b   Wanibuchi, Hideki ^b  

^a JAPAN INDUSTRIAL SAFETY AND HEALTH ASSOCIATION   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958775726     PISSN: 18807046     EISSN: 18807062     Source Type: Journal    
DOI: 10.3123/jemsge.31.33     Document Type: Article

References (11)

1. Kuraoka I. Effects of DNA lesions on transcription elongation by RNA polymerases. Genes and Environment.2008; 30: 63-70.
2. Kato T, Ohgaki H, Hasegawa H, Sato S, Takayama S, Sugimura T. Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-.] quinoxaline. Carcinogenesis. 1998; 9: 71-3.
3. Fukushima S, Wanibuchi H, Morimura K, Wei M, Nakae D, Konishi Y, Tsuda H, Uehara N, Imaida K, Shirai T, Tatematsu M, Tsukamoto T, Hirose M, Furukawa F, Wakabayashi K, Totsuka Y. Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-] quinoxaline or N-nitrosodiethylamine. Jpn J Cancer Res. 2002; 93: 1076-82.
4. Hoshi M, Morimura K, Wanibuchi H, Wei M, Okochi E, Ushijima T, Takaoka K, Fukushima S. No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogens. Toxicol Sci. 2004; 80: 1-7.
5. Fukushima S, Wanibuchi H, Morimura K, Wei M, Nakae D, Konishi Y, Tsuda H, Takasuka N, Imaida K, Shirai T, Tatematsu M, Tsukamoto T, Hirose M, Furukawa F. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-] quinoxaline. Cancer Lett. 2003; 191: 35-40.
6. Murai T, Mori S, Kang JS, Morimura K, Wanibuchi H, Totsuka Y, Fukushima S. Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-]quinoxaline liver carcinogenicity in F344DuCrj rats. Toxicol Pathol. 2008; 36: 472-7.
7. Peto R, Gray R, Brantom P, Grasso P. Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res. 1991; 51: 6415-51.
8. Fukushima S, Wanibuchi H, Morimura K, Nakae D, Tsuda H, Imaida K, Shirai T, Tatematsu M, Tsukamoto T, Hirose M, Furukawa F. Lack of potential of low dose N-nitrosodimethylamine to induce preneoplastic lesion, glutathione S-transferase placental form-positive foci, in rat liver. Cancer Lett. 2005; 222: 11-5.
9. Fukushima S, Wanibuchi H, Morimura K, Iwai S, Nakae D, Kishida H, Tsuda H, Uehara N, Imaida K, Shirai T, Tatematsu M, Tsukamoto T, Hirose M, Furukawa F. Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Toxicol Sci. 2004; 80: 109-14.
10. Kurokawa Y, Maekawa A, Takahashi M, Hayashi Y. Toxicity and carcinogenicity of potassium bromate-a new renal carcinogen. Environ Health Perspect. 1990; 87: 309-35.
11. Yamaguchi T, Wei M, Hagihara N, Omori M, Wanibuchi H, Fukushima S. Lack of mutagenic and toxic effects of low dose potassium bromate on kidneys in the Big Blue rat. Mutation Res. 2008; 652: 1-11.